These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms]. Inoue N, Tamura K, Kuroiwa Y, Ysukochi T, Naritomi T. Rinsho Shinkeigaku; 1973 Sep 18; 13(9):537-42. PubMed ID: 4796521 [No Abstract] [Full Text] [Related]
3. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3]. Aoyama H, Oira M, Ota T, Yoshioka S, Yoshida T. Nihon Eiseigaku Zasshi; 1970 Dec 18; 25(5):468-71. PubMed ID: 4251106 [No Abstract] [Full Text] [Related]
4. [Subacute myelo-optico-neuropathy (SMON) in Japan. The question of chinoform poisoning]. Igata A, Toyokura Y. Munch Med Wochenschr; 1971 Jul 30; 113(31):1062-6. PubMed ID: 5109393 [No Abstract] [Full Text] [Related]
5. Neuropathology of subacute myelo-optico-neuropathy, "SMON". Shiraki H. Jpn J Med Sci Biol; 1971 Aug 30; 24(4):217-43. PubMed ID: 5316312 [No Abstract] [Full Text] [Related]
6. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols. Selby G. Proc Aust Assoc Neurol; 1973 Aug 30; 9():23-30. PubMed ID: 4268933 [No Abstract] [Full Text] [Related]
7. Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey. Nakae K, Yamamoto S, Igata A. Lancet; 1971 Sep 04; 2(7723):510-2. PubMed ID: 4105662 [No Abstract] [Full Text] [Related]
9. [Subacute myelo-optico-neuropathy]. Folgerø B, Gundersen SG, Sigstad H. Tidsskr Nor Laegeforen; 1982 Jun 10; 102(16):896-7. PubMed ID: 7164039 [No Abstract] [Full Text] [Related]
10. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation]. Inoue N, Kuroiwa Y, Ikeda M, Yasukouchi T. Rinsho Shinkeigaku; 1974 Oct 10; 14(10):769-73. PubMed ID: 4282713 [No Abstract] [Full Text] [Related]
11. [Ocular disorders in SMON (subacute myelo-optico neuropathy), especially neuro-retinal lesions]. Okuda K, Matsuo H, Ueno H. Nippon Ganka Gakkai Zasshi; 1971 Oct 10; 75(8):1937-43. PubMed ID: 5165911 [No Abstract] [Full Text] [Related]
12. [Subacute myelo-optico neuropathy (SMON) in Hokkaido, an epidemiological study (report II). Considering age and sex as factors in SMON (author's transl)]. Kasai M. Nihon Eiseigaku Zasshi; 1974 Jun 10; 29(2):312-20. PubMed ID: 4475236 [No Abstract] [Full Text] [Related]
13. [Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)]. Tsubaki T. Nihon Naika Gakkai Zasshi; 1974 Jan 10; 63(1):1-17. PubMed ID: 4856733 [No Abstract] [Full Text] [Related]
14. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-. Shigematsu I. Jpn J Med Sci Biol; 1975 Jan 10; 28 Suppl():35-55. PubMed ID: 136540 [No Abstract] [Full Text] [Related]
15. [Differential diagnosis of subacute myelo-optico-neuropathy]. Tsubaki T. Saishin Igaku; 1969 Dec 10; 24(12):2465-8. PubMed ID: 5363406 [No Abstract] [Full Text] [Related]
16. Subacute myelo-optico-neuropathy (SMON). Nelson E. Ann Intern Med; 1972 Sep 10; 77(3):468-70. PubMed ID: 4262315 [No Abstract] [Full Text] [Related]